We have previously reported that chemotherapy-induced ovarian toxicity may derive from acute vascular insult, demonstrated by decreased ovarian blood flow and diminished post-treatment anti-Müllerian hormone (AMH) levels in a cohort of young breast cancer patients treated with chemotherapy. Here, AMH is linked to breast carcinoma.